View More Recent Stories
-
Citi Upgrades Sarepta Therapeutic (SRPT) to Neutral
-
Pre-Open Movers 4/21: (SRPT) (CBEY) (ASTM) Higher; (ATHN) (WLT) (PEIX) Lower (more...)
-
Pre-Open Stock Movers 1/16: (ZOOM) (SRPT) (CEC) Higher; (BBY) (NUS) (C) Lower (more...)
-
Sarepta Therapeutics (SRPT) on Watch as FDA Letter Circulates, Suggesting Wiggle Room for Eteplirsen Accelerated Approval
-
Unusual 11 Mid-Day Movers 01/06: (OXBT) (PPHM) (CTIC) Higher; (BCOV) (SCSS) (CHNR) Lower
-
Notable Analyst Rating Changes 01/06: (SCTY) (BSX) (AIG) Upgraded; (TWTR) (AAPL) (SRPT) Downgraded
-
UPDATE: Citi Downgrades Sarepta Therapeutic (SRPT) to Sell
-
Notable Analyst Rating Changes 11/12: (XTEX) (LF) (BCRX) Upgraded; (SRPT) (GOGO) (CLH) Downgraded
-
Notable 52-Week Highs and Lows of the Day 10/07: (MU) (CTIC) (GWPH) High; (ATOS) (JCP) (ACFN) Low
-
Citi Starts Sarepta Therapeutic (SRPT) at Neutral
-
Notable Analyst Rating Changes 07/24: (FTI) (AAPL) (ST) Upgraded; (BRCM) (SRPT) (PLCM) Downgraded
-
Notable Analyst Rating Changes 04/16: (MSFT) (S) (PXD) Upgraded; (SRPT) (SE) (CHRW) Downgraded
-
Market Wrap: U.S. Shaken on Marathon Bombings; Gold's Massive Plunge; DISH Bids for Sprint
-
Notable Analyst Rating Changes 01/25: (JPM) (TIF) (STM) Upgraded; (GS) (F) (UAL) Downgraded
-
StreetInsider.com Pre-Open Movers 11/21: (MEMS) (CRUS) (VELT) Higher; (SCHL) (TLYS) (DE) Lower (more...)
-
Pre-Open Movers 10/15: (CLWR) (EDU) (AEGR) Higher; (DCTH) (CNX) (ELN) Lower (more...)
-
Pre-Open Movers 10/03: (SRPT) (ITMN) (BBY) Higher; (XRTX) (ATRS) (SPN) Lower (more...)
-
Unusual 11 Mid-Day Movers 08/15: (SRPT) (WAVX) (AOSL) Higher; (GBG) (CTRN) (FES) Lower
-
Morning Movers 08/15: (FACE) (SRPT) (AOSL) Higher; (GBG) (CTRN) (FES) Lower
-
Unusual 11 Mid-Day Movers 07/24: (SPRT) (HSTM) (SANM) Higher; (GNTX) (DV) (WBMD) Lower
-
Morning Movers 07/24: (SRPT) (SANM) (CYNO) (DNDN) Higher; (DV) (GNTX) (WBMD) (BRKR) Lower

